Acute Coronary Syndrome: Epidemiology and Patient-Based Market Forecasts, Treatment Algorithm, and Marketed and Pipeline Drug Analysis

  • ID: 3797406
  • Drug Pipelines
  • 229 pages
  • Datamonitor Healthcare
1 of 3
The $1.9bn acute coronary syndrome (ACS) market will experience moderate growth over the forecast period, driven by uptake of Brilinta and Xarelto in the secondary-prevention setting.

This report addresses the following questions:

- How will the updated 2016 treatment guidelines impact the use of new antiplatelet agents Effient and Brilinta?
- How will Brilinta’s label expansion impact its sales within ACS?
- How will Xarelto’s expected US approval in ACS affect its patient share in comparison to generic warfarin?
- What are the most commonly prescribed therapies for ACS in the acute and secondary-prevention treatment settings?
- What are the most important factors influencing prescribing trends in ACS?
Note: Product cover images may vary from those shown
2 of 3
FORECAST: ACUTE CORONARY SYNDROME

- Executive Summary
- Market Overview and Trends
- Market Definition and Methodology
- Angiomax (bivalirudin)
- Brilinta (ticagrelor)
- Effient (prasugrel)
- Kengreal (cangrelor)
- Plavix (clopidogrel)
- Xarelto (rivaroxaban)
- Zontivity (vorapaxar)
- Primary Research Methodology

TREATMENT: ACUTE CORONARY SYNDROME

- Executive Summary
- Primary Research Methodology
- Disease Definition and Diagnosis
- Patient Segmentation
- Country Treatment Trees
- Prescribing Trends

EPIDEMIOLOGY: ACUTE CORONARY SYNDROME IN THE US, JAPAN, AND 5EU

- Executive Summary
- Disease Definition
- Global Variation
- Risk Factors
- Co-Morbidities
- Sources and Methodology
- Forecast
- Epidemiologist Insight
- Strengths and Limitations
- Bibliography

MARKETED DRUGS: ACUTE CORONARY SYNDROME

- Executive Summary
- Product Overview
- Product profile: Angiomax
- Product profile: Brilinta
- Product profile: Effient
- Product profile: Kengreal
- Product profile: Plavix
- Product profile: Xarelto
- Product profile: Zontivity
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll